Alnylam Sees FY Non-GAAP Operating Loss To Be Substantially

Alnylam Sees FY Non-GAAP Operating Loss To Be Substantially Improved

WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals Inc. (ALNY) said that it expects its full year 2021 non-GAAP operating loss to be substantially improved relative to the prior year.As of on December

Related Keywords

Washington , United States , , Alnylam Pharmaceuticals Inc , Alnylam , Fees , Aap , Operating , Boss , Substantially , Mproved ,

© 2025 Vimarsana